Remove Bicuspid/Mitral Remove Open-Heart Surgery Remove Technology
article thumbnail

HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study for treatment of Mitral Regurgitation

DAIC

milla1cf Mon, 06/03/2024 - 12:36 June 3, 2024 — HighLife SAS , a medtech company focused on the development of a novel Trans-Septal Mitral Valve Replacement (“TSMVR”) system to treat patients suffering from moderate to severe Mitral Regurgitation (MR), announced today that the U.S. I am honored to lead the HighLife pivotal study.

article thumbnail

Atrium Health Sanger Heart & Vascular Institute Performs Landmark Heart Valve Surgery

DAIC

milla1cf Mon, 06/10/2024 - 17:58 June 10, 2024 — Atrium Health Sanger Heart & Vascular Institute has successfully completed the first commercial tricuspid clip procedure in the Carolinas, performed in May at Atrium Health Carolinas Medical Center. This procedure has since become a cornerstone in the field of structural heart interventions.

article thumbnail

Henry Ford Health Heart Failure Patient First in Michigan to Receive Breakthrough Device

DAIC

This is really the first valve that can be delivered via catheter where previously open-heart surgery was the only option for patients healthy enough to undergo the procedure,” said Brian O’Neill, M.D. director of Interventional and Structural Heart Research at Henry Ford Hospital. William O’Neill, M.D.

article thumbnail

FDA Advisory Committee Votes in Favor of Abbott’s First-of-its-kind Triclip System to Treat People with a Leaky Tricuspid Heart Valve

DAIC

"Tricuspid regurgitation can put added strain on the heart and lead to other cardiovascular issues, which can significantly worsen a person's quality of life, but historically there have been few treatment options," said Lars Søndergaard , M.D.,

Tricuspid 102
article thumbnail

The Nation’s Heart: Ghana

Global Cardiac Surgery

Documented reports in Ghana go back to 1964 with the use of surface cooling to close atrial septal defects (ASDs) and performing a closed mitral commissurotomy at the Korle-Bu Teaching Hospital in Accra, under Charles Easmon, general surgeon and head of the Surgery Department at the hospital.

article thumbnail

Abbott Announces FDA Approval of First-of-its-kind Device to Repair Leaky Tricuspid Heart Valve, TriClip

DAIC

Sorajja added, "With TriClip, physicians can offer patients a therapy option backed by excellent safety and effectiveness to help restore tricuspid native valve performance without subjecting them to high-risk open-heart surgery that may not be feasible for individuals with TR who are generally older and sicker."

Tricuspid 105